SCHEMBL4045002

SCHEMBL4045002

c1ccc(COc2nn(CCN3CCCCC3)cc2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HRH3 Q9Y5N1 5/20 0.46
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 5/20 0.46
NPY1R P25929 1/20 0.46
MCHR1 Q99705 3/20 0.44
HRH1 P35367 1/20 0.44
KCNH2 Q12809 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2577848 1.00 LTA4H (0.47) LTA4HNPC1RAB9ASMN1; SMN2HRH3
SCHEMBL1385833 0.99 LTA4H (0.48) LTA4HNPC1RAB9ASMN1; SMN2HRH3
Hydrochloric Acid SCHEMBL2583849 0.98 LTA4H (0.47) LTA4HNPC1RAB9ASMN1; SMN2HRH3
Oxalic Acid SCHEMBL2575764 0.94 NPC1 (0.56) NPC1RAB9ASMN1; SMN2HRH3KDM4E
SCHEMBL2576788 0.93 PDE10A (0.45) LTA4HNPC1RAB9ASMN1; SMN2HRH3
Oxalic Acid SCHEMBL2582750 0.93 KDM4E (0.55) NPC1RAB9ASMN1; SMN2HRH3KDM4E
SCHEMBL2575882 0.92 CNR1 (0.44) LTA4HNPC1RAB9ASMN1; SMN2HRH3
SCHEMBL2582255 0.92 KCNH2 (0.43) LTA4HNPC1RAB9ASMN1; SMN2HRH3
SCHEMBL2580788 0.92 LTA4H (0.43) LTA4HNPC1RAB9ASMN1; SMN2HRH3
SCHEMBL2579448 0.92 BCHE (0.45) LTA4HNPC1RAB9ASMN1; SMN2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689720-B1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2009-04-15 EP disclosed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP disclosed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO disclosed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO disclosed